Published Date:2022-09-23 Original Link:https://www.onenessbio.com/en/news_detail178_1.htm No 2 Date of announcement 2022/09/23 Time of announcement  17:37:19 Subject Oneness announces the information about the investor’s conference of 2022 Q3. To which item it meets paragraph 12 Date of events 2022/09/30 Statement Date of institutional investor conference:2022/09/30 Time of institutional investor conference:15:00 (GMT+8) Location of institutional investor conference:Online Investor...Read More

Published Date:2022-09-23 Original Link:https://www.onenessbio.com/en/news_detail177_1.htm No 1 Date of announcement 2022/09/23 Time of announcement 17:14:21 Subject SNS812, a broad-spectrum siRNA co-developed by Oneness and Microbio (Shanghai) to treat SARS-CoV-2 infection, was greenlighted by FDA to proceed with a Ph1 study To which item it meets paragraph 10 Date of events 2022/09/23 Statement Product:SNS812, a broad-spectrum siRNA...Read More